Pesticide-Induced Release From Competition Among Competing <I>Aedes aegypti</I> and <I>Aedes albopictus</I> (Diptera: Culicidae)

Abstract

Competitive interactions between mosquitoes Aedes aegypti (L.) and Aedes albopictus (Skuse) may depend on environmental conditions. Pesticides may alleviate density-dependent competition for limited food, and a differential species response to sublethal concentrations may modify interspecific competition. We tested the hypothesis that exposure to malathion alters interspecific resource competition between these two species. In the absence of malathion, Ae. aegypti survivorship and per capita rate of population change were negatively affected by increasing densities of Ae. albopictus. However, the asymmetrical negative effect ofAe. albopictus on Ae. aegypti was eliminated in the presence of malathion. In addition, the presence of malathion resulted in shorter development time compared with the controls. The relative importance of pesticide-mediated coexistence in nature has not been evaluated, so its role in mediating coexistence is unclear; however, these findings underscore the potential of environmental concentrations of malathion, and perhaps other pesticides to facilitate coexistence between species.

Exploiting evolutionary herding to control drug resistance in cancer

“…Instead, controlling the disease, rather than attempting to cure it, may be the only viable option in advanced cancers (Gatenby et al, 2009). Although this sounds radical in Oncology, disease management is well established in fields such as HIV (Ghosn et al, 2018) and antibiotic resistance (Nichol et al, 2015), as well as pest control (Alto et al, 2013;Neve et al, 2009;Oliveira et al, 2007). In cancer, different groups have explored this concept of 'adaptive therapy' (Gatenby et al, 2009) where drug dose is modulated in response to the underling evolutionary dynamics (Enriquez-Navas et al, 2016;Gallaher et al, 2018), with encouraging preliminary results in clinical trials (Zhang et al, 2017).…”

Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging

“…, that we should treat diseases using the most potent drug with the highest tolerable dose for the longest possible time until the disease is cured, the therapy ceases to be effective, or the drugs become too toxic. Mathematical models of disease progression assuming genetically driven resistance indicate that this approach could drive the emergence of resistance through an ecological principle called competitive release (Alto et al 2013; Adkins and Shabbir 2014). Before treatment, cells compete with one another for limited resources within a spatially constrained population.…”

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer

“…The evolutionary consequences of this trade-off are demonstrated by observations that P-glycoprotein–expressing cells (MCF7-dox) revert to wild type unless doxorubicin is maintained in the culture media as a strong selection force (17). In this Darwinian setting, maximum dose density therapy strongly selects for resistant phenotypes and, by removing all competitors, permits unconstrained proliferation of the resistant populations even when no drug is present—a phenomenon well recognized in evolutionary dynamics as “competitive release” (18, 19). …”